Top 15 Life Science Startup Investors in Austria in February 2025
A list of 15 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Austria. We rank investors based on the number of investments they made in Life science companies from Austria. We update this investor list every month.Top 15 Life Science Startup Investors in Austria in February 2025
Investor | Life Science Austria investments |
---|---|
xista science ventures | 3 |
xista science ventures | 3 |
Longevitytech.fund | 2 |
APEX Ventures | 2 |
APEX Ventures | 2 |
R42 Group | 2 |
Nina Capital | 2 |
Biogena | 1 |
Axilium Holding | 1 |
SOSV | 1 |
Lansdowne Investment Company Cyprus | 1 |
tecnet equity | 1 |
Pace Ventures | 1 |
NovaCapital | 1 |
Polaris Partners | 1 |
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Medical Device
- Seed, Pre-Seed, Series A
- Austria, France, Slovenia
Portfolio highlights
- Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
- Biotechnology, Health Care, Personal Health
- Seed, Convertible Note, Pre-Seed
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Funding Round, Pre-Seed
- United Kingdom, United States, Austria
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
Biogena develops, produces & markets high-quality dietary supplements.
Show more
Investment focus
- Food and Beverage, Fitness, Health Care
- Seed
- Austria, United States
Portfolio highlights
- NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
- Saturo — Saturo is Europe’s first meal replacement product in a bottle, offering balanced and healthy nutrition.
- Luminous Labs GmbH — Welcome to Luminous Labs - we are one of the leading photobiomodulation and red light therapy companies in Europe. With a strong focus on research and development we are expanding the human health-span with our non-invasive technology. One photon at a time, starting with female fertility and longevity.
Axilium Holding
Show more
Investment focus
- Life Science, Biotechnology, Semiconductor
- Seed
- Austria
Portfolio highlights
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Lansdowne Investment Company Cyprus
Show more
Investment focus
- Life Science, Biotechnology, Semiconductor
- Seed
- Austria
Portfolio highlights
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
Investing at the intersection of climate and health.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Funding Round, Pre-Seed
- United States, Germany, Austria
Portfolio highlights
- Clearly.Earth — Decarbonise your fleet whilst saving costs
- Turnover Labs — Turnover Labs strives to decarbonize the chemical production business and transform how the world generates petrochemicals.
- Dunia Innovation — Catalysing the energy transition.
NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Series A
- Italy, Austria
Portfolio highlights
- Ekore — Miglioriamo la gestione degli edifici ottimizzando i consumi e la gestione delle manutenzioni tramite il concetto di Digital Twin.
- ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
- Newarc srl — With the help of technology, we simplify and improve the home buying and selling process.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- United States, Singapore, Ireland
Portfolio highlights
- TRex Bio — TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us toidentify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.
- Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
- Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Investors by industry
Biotech
Energy
Health Care
Hardware
Gaming
Google
Artificial intelligence
Climate
Proptech
Community
FinTech
Consumer
Marketplace
Impact
EdTech
Sustainability
Venture Capital
Retail
Clean Energy
Finance
Education
Organic Food
Big Data
Web3
Food and Beverage
Financial Services
Payments
B2B
Real Estate
Publishing
Video Games
Beauty
Infrastructure
Photography
Medical
Social Network
Wellness
Music
Franchise
Mobile
Internet
Legal
Android
eSports
Construction
Sports
Enterprise Software
Social Media
Email
Art
Digital Media
Manufacturing
Local
Cannabis
Biotechnology
Recruiting
Fitness
Hospitality
Platforms
Mobile Advertising
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Oil and Gas
Fashion
Theatre
Life Science
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
United Kingdom
Germany
United States
South Korea
Canada
Ireland
Australia
New Zealand
Oceania
LATAM
Africa
Asia
Japan
Saudi Arabia
China
Singapore
Spain
Vietnam
Faroe Islands
Barbados
Denmark
Chile
Ecuador
Ethiopia
Estonia
Hong Kong
France
Gibraltar
Costa Rica
Armenia
Greece
Finland
Croatia
Egypt
Georgia
Algeria
Ghana
Bulgaria
Bermuda
Hungary
Czech Republic
Bahrain
Belize
Belgium
South Africa
Belarus
Liechtenstein
Morocco
Liberia
Lebanon
Lithuania
Kuwait
Philippines
Mexico
Norway
Jersey
Mauritius
Israel
Malaysia
Peru
Malta
Myanmar
Italy
Mali
Nicaragua
Panama
Serbia
Ukraine
Uganda
Uzbekistan
Thailand
Portugal
Senegal
Sierra Leone
Venezuela
Russian Federation
Tajikistan
Rwanda
Zimbabwe
Zambia
Seychelles
Taiwan
Sweden
El Salvador
Tunisia
San Marino
Poland
Turkey
Puerto Rico
Uruguay
Slovenia
Togo
Tanzania
Dominican Republic
Iraq
Nigeria
Bahamas
Namibia
Azerbaijan
Iceland
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Middle East
Pakistan
Albania
Sri Lanka
Brazil
Bangladesh
Indonesia
Grenada
Romania
Jordan
Argentina
Europe
Qatar
Kazakhstan
Kenya
Cayman Islands
Cambodia
Latvia
Oman
Cyprus
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Guatemala
Investors in Austria by industry
Transportation
Music
Cryptocurrency
Education
Finance
Food and Beverage
Real Estate
Organic Food
Medical
Internet
Manufacturing
Wellness
Digital Media
Android
Mobile
Blockchain
Local
Software
Enterprise Software
Sports
eSports
Fitness
Automotive
Hospitality
Travel
InsurTech
Platforms
Recruiting
FinTech
Biotechnology
Consumer
Health Care
EdTech
Energy
Sustainability
Climate
Impact
Marketplace
Proptech
SaaS
Artificial intelligence
Hardware
Gaming
Mobile Apps
Web3
B2B
Life Science
Sporting Goods
Publishing
Renewable Energy
Financial Services
Biotech
Enterprise
Medical Device
Big Data
Social Impact
Social Media
Art
Agriculture (agtech)
Media (entertainment)
Construction
Community
CleanTech
Retail
Payments